Latest News - Cardinal Health
Top Corporates Hub
Cardinal Health
1 of Wall Street’s Favorite Stock with Competitive Advantages and 2 We Find Risky
23.05.2026 10:20
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Possible Bearish Signals With Cardinal Health Insiders Disposing Stock
20.05.2026 13:00
Over the past year, many Cardinal Health, Inc. ( NYSE:CAH ) insiders sold a significant stake in the company which may...
Does Cardinal Health's (CAH) Higher Dividend and Guidance Hint at a New Capital Allocation Play?
16.05.2026 07:16
Earlier this month, Cardinal Health, Inc. declared a quarterly dividend of US$0.5158 per share, payable on July 15, 2026, to shareholders of record as of July 1, 2026. This dividend move comes alongside upgraded fiscal 2026 earnings guidance and strong momentum in the Pharmaceutical & Specialty Solutions segment, especially specialty therapies. We’ll now examine how Cardinal Health’s raised fiscal 2026 earnings guidance may affect its investment narrative and longer-term business...
Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference
15.05.2026 11:00
Nutriband’s Active Intelligence subsidiary to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference Company to Meet with Buyers from Walmart Inc, Walgreens, Amazon.com, Inc., Cardinal Health and Other Major National Retailers ORLANDO, Fla., May 15, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) and its wholly owned subsidiary Active Intelligence (“Active Intelligence” or the “Company”), an emerging leader in innovative wellness, re
Baird Keeps Outperform on Cardinal Health (CAH) Following Earnings Update
14.05.2026 05:09
Cardinal Health, Inc. (NYSE:CAH) is included among the 10 Best Stocks to Buy Now for a $1 Million Portfolio. On May 1, Baird lowered its price recommendation on Cardinal Health, Inc. (NYSE:CAH) to $248 from $257. It reiterated an Outperform rating on the shares. The firm updated its model following the company’s first-quarter results and […]
2 Reasons to Like CAH and 1 to Stay Skeptical
13.05.2026 02:20
Over the past six months, Cardinal Health’s stock price fell to $186.14. Shareholders have lost 9.4% of their capital, which is disappointing considering the S&P 500 has climbed by 7.7%. This might have investors contemplating their next move.
[Latest] Global Surgical Case Carts Market Size/Share Worth USD 686.99 Million by 2035 at a 4.04% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
08.05.2026 11:30
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Surgical Case Carts Market size & share revenue was valued at approximately USD 462.33 Million in 2025 and is expected to reach USD 481 Million in 2026 and is expected to reach around USD 686.99 Million by 2035, at a CAGR of 4.04% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Getinge, Stryker, Medline
Brokers Suggest Investing in Cardinal (CAH): Read This Before Placing a Bet
07.05.2026 13:30
The average brokerage recommendation (ABR) for Cardinal (CAH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Cardinal (CAH) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
04.05.2026 13:55
Cardinal (CAH) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Stryker Q1 Earnings & Sales Miss Estimates on Cyber Disruption
01.05.2026 14:26
SYK misses Q1 earnings and revenue estimates as a cyber incident disrupts production, dents margins, and slows growth despite gains across key segments.
Merit Medical Q1 Earnings & Revenues Beat Estimates, Sales View Up
01.05.2026 14:14
MMSI tops Q1 estimates with 9% EPS growth and 7% revenue rise, while lifting its 2026 sales outlook amid steady segment and geographic gains.
Cardinal Health Q3 Earnings Call Highlights
01.05.2026 07:27
Cardinal Health (NYSE:CAH) reported what executives described as “another strong quarter” in fiscal third-quarter 2026, citing broad-based demand, continued momentum in pharmaceutical distribution and specialty, and solid performance from its faster-growing businesses. Management also raised full-ye
William Blair Initiates Cardinal Health at Outperform: Is the Pharma Distributor a Stealth Compounder?
28.04.2026 15:55
William Blair launched coverage of Cardinal Health (NYSE:CAH) with an Outperform rating today, framing the pharma distributor as a durable franchise with specialty-led upside. The firm simultaneously initiated McKesson (NYSE:MCK) at Outperform, a dual launch that signals conviction in the U.S. drug-distribution oligopoly. For prudent investors, the call tightens an already constructive sell-side picture on ... William Blair Initiates Cardinal Health at Outperform: Is the Pharma Distributor a Ste
Jim Cramer says health care is the 'cold' hedge your AI-heavy portfolio is missing — and shares 4 stocks to consider
28.04.2026 15:45
AI stocks have powered the market higher, but Jim Cramer says overlooked health care names could offer stability if the rally starts to cool.
Micron initiated, Rambus downgraded: Wall Street's top analyst calls
28.04.2026 14:19
Micron initiated, Rambus downgraded: Wall Street's top analyst calls
Henry Schein (HSIC) Reports Next Week: Wall Street Expects Earnings Growth
28.04.2026 14:00
Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ahead of Cardinal (CAH) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
28.04.2026 13:15
Besides Wall Street's top-and-bottom-line estimates for Cardinal (CAH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2026.
How The Cardinal Health (CAH) Story Is Shifting As Analysts Rework Targets And Fair Value
25.04.2026 09:08
Cardinal Health’s fair value estimate was nudged from US$249.60 to about US$248.27 per share, signalling a small recalibration rather than a wholesale rethink. That shift sits alongside a cluster of Street price target moves, with several firms lifting targets into the mid to high US$200s and one house cutting its view by about US$20 as analysts reassess what is already reflected in the share price. As you read on, you will see how these shifting targets and narratives can help you track...
Ecolab Debuts AI Platform to Optimize Water Intelligence & Performance
23.04.2026 16:15
ECL unveils AI-powered Water Navigator IQ to help businesses track water use, manage risk and turn insights into growth as global scarcity intensifies.
Here's Why You Should Hold OPK Stock in Your Portfolio for Now
23.04.2026 16:07
OPKO Health rides on RAYALDEE strength, partnerships and restructuring gains, but reliance on a single drug keeps risk in focus for investors.